Literature DB >> 12004462

Improving adverse-drug-reaction reporting in ambulatory care clinics at a Veterans Affairs hospital.

Monica B Aspinall1, Jeff Whittle, Sherrie L Aspinall, Robert L Maher, Chester B Good.   

Abstract

The detection of adverse drug reactions (ADRs) by a traditional passive reporting system and by a method involving patient and provider interviews was studied. The study sample consisted of randomly selected outpatients seen by their primary care provider during scheduled appointments in January and February 2001 at a Veterans Affairs medical center. After ambulatory care clinic sessions, patients and providers were asked (by telephone and in person, respectively) to identify potential ADRs. Also obtained were demographic data, information about drug regimens, and the severity and management of each ADR. A standardized ADR-assessment tool was used to determine the severity of each reported reaction and its causal relationship with the medication. A total of 198 patients were included. Of these, 51 (26%) had one or more ADRs. The patient and provider interviews identified a total of 83 ADRs, compared with 1 ADR identified by the passive reporting system. When providers were made aware of the ADRs they had not identified, changes were made to the patient's medication regimen in 34% of cases. The risk of an ADR was not associated with age, number of medications, or provider type. Direct patient and provider interviews yielded a significantly higher rate of ADR detection in an ambulatory care setting than did a passive ADR-reporting system.

Entities:  

Mesh:

Year:  2002        PMID: 12004462     DOI: 10.1093/ajhp/59.9.841

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  7 in total

Review 1.  Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.

Authors:  A Blenkinsopp; P Wilkie; M Wang; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  2007-02       Impact factor: 4.335

2.  A Review of Pharmacovigilance.

Authors:  J E Campbell; M Gossell-Williams; M G Lee
Journal:  West Indian Med J       Date:  2015-03-05       Impact factor: 0.171

Review 3.  Strategies to improve adverse drug reaction reporting: a critical and systematic review.

Authors:  Cristian Gonzalez-Gonzalez; Elena Lopez-Gonzalez; Maria T Herdeiro; Adolfo Figueiras
Journal:  Drug Saf       Date:  2013-05       Impact factor: 5.606

4.  Improving reporting of adverse drug reactions: Systematic review.

Authors:  Mariam Molokhia; Shivani Tanna; Derek Bell
Journal:  Clin Epidemiol       Date:  2009-08-09       Impact factor: 4.790

5.  Incidence, preventability, and causality of adverse drug reactions at a university hospital emergency department.

Authors:  Mirjam Kauppila; Janne T Backman; Mikko Niemi; Outi Lapatto-Reiniluoto
Journal:  Eur J Clin Pharmacol       Date:  2020-11-13       Impact factor: 2.953

6.  Prevalence of adverse drug reactions in the primary care setting: A systematic review and meta-analysis.

Authors:  Widya N Insani; Cate Whittlesea; Hassan Alwafi; Kenneth K C Man; Sarah Chapman; Li Wei
Journal:  PLoS One       Date:  2021-05-26       Impact factor: 3.240

Review 7.  Eliciting adverse effects data from participants in clinical trials.

Authors:  Elizabeth N Allen; Clare Ir Chandler; Nyaradzo Mandimika; Cordelia Leisegang; Karen Barnes
Journal:  Cochrane Database Syst Rev       Date:  2018-01-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.